Skip to main navigation Skip to search Skip to main content

Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus

  • Yu Luo
  • , Jia Ping Yao
  • , Li Yang
  • , Chun Lan Feng
  • , Wei Tang
  • , Gui Feng Wang
  • , Jian Pin Zuo*
  • , Wei Lu
  • *Corresponding author for this work
  • East China Normal University
  • CAS - Shanghai Institute of Materia Medica

Research output: Contribution to journalArticlepeer-review

Abstract

A series of novel benzimidazole derivatives were synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in the HepG2.2.15 cell line. The preliminary SAR was discussed. Compound 12a, with IC 50 <0.41 μM and SI >81.2, was the most promising compound and selected as the benchmark compound for further optimization.

Original languageEnglish
Pages (from-to)5048-5055
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume18
Issue number14
DOIs
StatePublished - 15 Jul 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-HBV activity
  • Benzimidazoles

Fingerprint

Dive into the research topics of 'Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus'. Together they form a unique fingerprint.

Cite this